id	sid	tid	token	lemma	pos
cord-328210-qhl429fm	1	1	key	key	NN
cord-328210-qhl429fm	1	2	:	:	:
cord-328210-qhl429fm	2	1	cord-328210-qhl429fm	cord-328210-qhl429fm	NNP
cord-328210-qhl429fm	2	2	authors	author	NNS
cord-328210-qhl429fm	2	3	:	:	:
cord-328210-qhl429fm	2	4	Gelardi	Gelardi	NNP
cord-328210-qhl429fm	2	5	,	,	,
cord-328210-qhl429fm	2	6	Matteo	Matteo	NNP
cord-328210-qhl429fm	2	7	;	;	:
cord-328210-qhl429fm	2	8	Cassano	Cassano	NNP
cord-328210-qhl429fm	2	9	,	,	,
cord-328210-qhl429fm	2	10	Michele	Michele	NNP
cord-328210-qhl429fm	2	11	;	;	:
cord-328210-qhl429fm	2	12	Ciprandi	Ciprandi	NNP
cord-328210-qhl429fm	2	13	,	,	,
cord-328210-qhl429fm	2	14	Giorgio	Giorgio	NNP
cord-328210-qhl429fm	2	15	title	title	NN
cord-328210-qhl429fm	2	16	:	:	:
cord-328210-qhl429fm	3	1	The	the	DT
cord-328210-qhl429fm	3	2	clinical	clinical	JJ
cord-328210-qhl429fm	3	3	relevance	relevance	NN
cord-328210-qhl429fm	3	4	of	of	IN
cord-328210-qhl429fm	3	5	the	the	DT
cord-328210-qhl429fm	3	6	clinical	clinical	JJ
cord-328210-qhl429fm	3	7	cytological	cytological	JJ
cord-328210-qhl429fm	3	8	grading	grading	NN
cord-328210-qhl429fm	3	9	in	in	IN
cord-328210-qhl429fm	3	10	patients	patient	NNS
cord-328210-qhl429fm	3	11	with	with	IN
cord-328210-qhl429fm	3	12	chronic	chronic	JJ
cord-328210-qhl429fm	3	13	rhinosinusitis	rhinosinusitis	NN
cord-328210-qhl429fm	3	14	with	with	IN
cord-328210-qhl429fm	3	15	nasal	nasal	JJ
cord-328210-qhl429fm	3	16	polyps	polyp	NNS
cord-328210-qhl429fm	3	17	date	date	NN
cord-328210-qhl429fm	3	18	:	:	:
cord-328210-qhl429fm	3	19	2020	2020	CD
cord-328210-qhl429fm	3	20	-	-	HYPH
cord-328210-qhl429fm	3	21	06	06	CD
cord-328210-qhl429fm	3	22	-	-	HYPH
cord-328210-qhl429fm	3	23	24	24	CD
cord-328210-qhl429fm	3	24	journal	journal	NN
cord-328210-qhl429fm	3	25	:	:	:
cord-328210-qhl429fm	4	1	J	J	NNP
cord-328210-qhl429fm	4	2	Allergy	Allergy	NNP
cord-328210-qhl429fm	4	3	Clin	Clin	NNP
cord-328210-qhl429fm	4	4	Immunol	Immunol	NNP
cord-328210-qhl429fm	4	5	DOI	DOI	NNP
cord-328210-qhl429fm	4	6	:	:	:
cord-328210-qhl429fm	4	7	10.1016	10.1016	CD
cord-328210-qhl429fm	4	8	/	/	SYM
cord-328210-qhl429fm	4	9	j.jaci.2020.04.049	j.jaci.2020.04.049	XX
cord-328210-qhl429fm	4	10	sha	sha	NNP
cord-328210-qhl429fm	4	11	:	:	:
cord-328210-qhl429fm	4	12	cca4c7aa2d13ec7e15f6e39e7c154ec050bb6278	cca4c7aa2d13ec7e15f6e39e7c154ec050bb6278	NFP
cord-328210-qhl429fm	4	13	doc_id	doc_id	CD
cord-328210-qhl429fm	4	14	:	:	:
cord-328210-qhl429fm	4	15	328210	328210	CD
cord-328210-qhl429fm	4	16	cord_uid	cord_uid	NNS
cord-328210-qhl429fm	4	17	:	:	:
cord-328210-qhl429fm	5	1	qhl429fm	qhl429fm	NNP
cord-328210-qhl429fm	5	2	nan	nan	NNP
cord-328210-qhl429fm	6	1	The	the	DT
cord-328210-qhl429fm	6	2	clinical	clinical	JJ
cord-328210-qhl429fm	6	3	relevance	relevance	NN
cord-328210-qhl429fm	6	4	of	of	IN
cord-328210-qhl429fm	6	5	the	the	DT
cord-328210-qhl429fm	6	6	clinical	clinical	JJ
cord-328210-qhl429fm	6	7	cytological	cytological	JJ
cord-328210-qhl429fm	6	8	grading	grading	NN
cord-328210-qhl429fm	6	9	in	in	IN
cord-328210-qhl429fm	6	10	patients	patient	NNS
cord-328210-qhl429fm	6	11	with	with	IN
cord-328210-qhl429fm	6	12	chronic	chronic	JJ
cord-328210-qhl429fm	6	13	rhinosinusitis	rhinosinusitis	NN
cord-328210-qhl429fm	6	14	with	with	IN
cord-328210-qhl429fm	6	15	nasal	nasal	NN
cord-328210-qhl429fm	6	16	polyps	polyp	NNS
cord-328210-qhl429fm	6	17	To	to	IN
cord-328210-qhl429fm	6	18	the	the	DT
cord-328210-qhl429fm	6	19	Editor	editor	NN
cord-328210-qhl429fm	6	20	:	:	:
cord-328210-qhl429fm	6	21	Smell	Smell	NNP
cord-328210-qhl429fm	6	22	dysfunction	dysfunction	NN
cord-328210-qhl429fm	6	23	is	be	VBZ
cord-328210-qhl429fm	6	24	a	a	DT
cord-328210-qhl429fm	6	25	common	common	JJ
cord-328210-qhl429fm	6	26	symptom	symptom	NN
cord-328210-qhl429fm	6	27	and	and	CC
cord-328210-qhl429fm	6	28	has	have	VBZ
cord-328210-qhl429fm	6	29	a	a	DT
cord-328210-qhl429fm	6	30	diagnostic	diagnostic	JJ
cord-328210-qhl429fm	6	31	value	value	NN
cord-328210-qhl429fm	6	32	in	in	IN
cord-328210-qhl429fm	6	33	the	the	DT
cord-328210-qhl429fm	6	34	workup	workup	NN
cord-328210-qhl429fm	6	35	of	of	IN
cord-328210-qhl429fm	6	36	patients	patient	NNS
cord-328210-qhl429fm	6	37	with	with	IN
cord-328210-qhl429fm	6	38	chronic	chronic	JJ
cord-328210-qhl429fm	6	39	rhinosinusitis	rhinosinusitis	NN
cord-328210-qhl429fm	6	40	with	with	IN
cord-328210-qhl429fm	6	41	nasal	nasal	NN
cord-328210-qhl429fm	6	42	polyps	polyp	NNS
cord-328210-qhl429fm	6	43	(	(	-LRB-
cord-328210-qhl429fm	6	44	CRSwNP	crswnp	RB
cord-328210-qhl429fm	6	45	)	)	-RRB-
cord-328210-qhl429fm	6	46	as	as	IN
cord-328210-qhl429fm	6	47	recently	recently	RB
cord-328210-qhl429fm	6	48	outlined	outline	VBN
cord-328210-qhl429fm	6	49	by	by	IN
cord-328210-qhl429fm	6	50	Mullol	Mullol	NNP
cord-328210-qhl429fm	6	51	et	et	NNP
cord-328210-qhl429fm	6	52	al	al	NNP
cord-328210-qhl429fm	6	53	.	.	.
cord-328210-qhl429fm	7	1	1	1	LS
cord-328210-qhl429fm	8	1	Notably	notably	RB
cord-328210-qhl429fm	8	2	,	,	,
cord-328210-qhl429fm	8	3	loss	loss	NN
cord-328210-qhl429fm	8	4	of	of	IN
cord-328210-qhl429fm	8	5	smell	smell	NN
cord-328210-qhl429fm	8	6	has	have	VBZ
cord-328210-qhl429fm	8	7	been	be	VBN
cord-328210-qhl429fm	8	8	proposed	propose	VBN
cord-328210-qhl429fm	8	9	as	as	IN
cord-328210-qhl429fm	8	10	one	one	CD
cord-328210-qhl429fm	8	11	of	of	IN
cord-328210-qhl429fm	8	12	the	the	DT
cord-328210-qhl429fm	8	13	main	main	JJ
cord-328210-qhl429fm	8	14	criteria	criterion	NNS
cord-328210-qhl429fm	8	15	for	for	IN
cord-328210-qhl429fm	8	16	an	an	DT
cord-328210-qhl429fm	8	17	indication	indication	NN
cord-328210-qhl429fm	8	18	of	of	IN
cord-328210-qhl429fm	8	19	and	and	CC
cord-328210-qhl429fm	8	20	response	response	NN
cord-328210-qhl429fm	8	21	to	to	IN
cord-328210-qhl429fm	8	22	the	the	DT
cord-328210-qhl429fm	8	23	new	new	JJ
cord-328210-qhl429fm	8	24	biological	biological	JJ
cord-328210-qhl429fm	8	25	treatments	treatment	NNS
cord-328210-qhl429fm	8	26	.	.	.
cord-328210-qhl429fm	9	1	2	2	LS
cord-328210-qhl429fm	10	1	Of	of	IN
cord-328210-qhl429fm	10	2	note	note	NN
cord-328210-qhl429fm	10	3	,	,	,
cord-328210-qhl429fm	10	4	it	-PRON-	PRP
cord-328210-qhl429fm	10	5	has	have	VBZ
cord-328210-qhl429fm	10	6	been	be	VBN
cord-328210-qhl429fm	10	7	very	very	RB
cord-328210-qhl429fm	10	8	recently	recently	RB
cord-328210-qhl429fm	10	9	reported	report	VBN
cord-328210-qhl429fm	10	10	that	that	IN
cord-328210-qhl429fm	10	11	a	a	DT
cord-328210-qhl429fm	10	12	significant	significant	JJ
cord-328210-qhl429fm	10	13	part	part	NN
cord-328210-qhl429fm	10	14	(	(	-LRB-
cord-328210-qhl429fm	10	15	20%-60	20%-60	CD
cord-328210-qhl429fm	10	16	%	%	NN
cord-328210-qhl429fm	10	17	)	)	-RRB-
cord-328210-qhl429fm	10	18	of	of	IN
cord-328210-qhl429fm	10	19	the	the	DT
cord-328210-qhl429fm	10	20	patients	patient	NNS
cord-328210-qhl429fm	10	21	with	with	IN
cord-328210-qhl429fm	10	22	coronavirus	coronavirus	NN
cord-328210-qhl429fm	10	23	disease	disease	NN
cord-328210-qhl429fm	10	24	2019	2019	CD
cord-328210-qhl429fm	10	25	(	(	-LRB-
cord-328210-qhl429fm	10	26	COVID-19	COVID-19	NNP
cord-328210-qhl429fm	10	27	)	)	-RRB-
cord-328210-qhl429fm	10	28	experienced	experience	VBD
cord-328210-qhl429fm	10	29	the	the	DT
cord-328210-qhl429fm	10	30	loss	loss	NN
cord-328210-qhl429fm	10	31	of	of	IN
cord-328210-qhl429fm	10	32	smell	smell	NN
cord-328210-qhl429fm	10	33	;	;	:
cord-328210-qhl429fm	10	34	anosmia	anosmia	NN
cord-328210-qhl429fm	10	35	can	can	MD
cord-328210-qhl429fm	10	36	be	be	VB
cord-328210-qhl429fm	10	37	the	the	DT
cord-328210-qhl429fm	10	38	first	first	JJ
cord-328210-qhl429fm	10	39	presenting	presenting	JJ
cord-328210-qhl429fm	10	40	symptom	symptom	NN
cord-328210-qhl429fm	10	41	and	and	CC
cord-328210-qhl429fm	10	42	so	so	RB
cord-328210-qhl429fm	10	43	the	the	DT
cord-328210-qhl429fm	10	44	European	European	NNP
cord-328210-qhl429fm	10	45	Rhinologic	Rhinologic	NNP
cord-328210-qhl429fm	10	46	Society	Society	NNP
cord-328210-qhl429fm	10	47	advised	advise	VBD
cord-328210-qhl429fm	10	48	that	that	IN
cord-328210-qhl429fm	10	49	patients	patient	NNS
cord-328210-qhl429fm	10	50	with	with	IN
cord-328210-qhl429fm	10	51	sudden	sudden	JJ
cord-328210-qhl429fm	10	52	-	-	HYPH
cord-328210-qhl429fm	10	53	onset	onset	NN
cord-328210-qhl429fm	10	54	loss	loss	NN
cord-328210-qhl429fm	10	55	of	of	IN
cord-328210-qhl429fm	10	56	smell	smell	NN
cord-328210-qhl429fm	10	57	should	should	MD
cord-328210-qhl429fm	10	58	be	be	VB
cord-328210-qhl429fm	10	59	considered	consider	VBN
cord-328210-qhl429fm	10	60	to	to	TO
cord-328210-qhl429fm	10	61	be	be	VB
cord-328210-qhl429fm	10	62	COVID-19	COVID-19	NNP
cord-328210-qhl429fm	10	63	positive	positive	JJ
cord-328210-qhl429fm	10	64	(	(	-LRB-
cord-328210-qhl429fm	10	65	www.europeanrhino	www.europeanrhino	NNP
cord-328210-qhl429fm	11	1	logicsociety.org	logicsociety.org	LS
cord-328210-qhl429fm	11	2	)	)	-RRB-
cord-328210-qhl429fm	11	3	.	.	.
cord-328210-qhl429fm	12	1	CRSwNP	CRSwNP	NNP
cord-328210-qhl429fm	12	2	is	be	VBZ
cord-328210-qhl429fm	12	3	characterized	characterize	VBN
cord-328210-qhl429fm	12	4	by	by	IN
cord-328210-qhl429fm	12	5	a	a	DT
cord-328210-qhl429fm	12	6	type	type	NN
cord-328210-qhl429fm	12	7	2	2	CD
cord-328210-qhl429fm	12	8	inflammation	inflammation	NN
cord-328210-qhl429fm	12	9	and	and	CC
cord-328210-qhl429fm	12	10	is	be	VBZ
cord-328210-qhl429fm	12	11	frequently	frequently	RB
cord-328210-qhl429fm	12	12	associated	associate	VBN
cord-328210-qhl429fm	12	13	with	with	IN
cord-328210-qhl429fm	12	14	some	some	DT
cord-328210-qhl429fm	12	15	comorbidity	comorbidity	NN
cord-328210-qhl429fm	12	16	,	,	,
cord-328210-qhl429fm	12	17	including	include	VBG
cord-328210-qhl429fm	12	18	asthma	asthma	NN
cord-328210-qhl429fm	12	19	,	,	,
cord-328210-qhl429fm	12	20	aspirin	aspirin	NN
cord-328210-qhl429fm	12	21	sensitivity	sensitivity	NN
cord-328210-qhl429fm	12	22	,	,	,
cord-328210-qhl429fm	12	23	and	and	CC
cord-328210-qhl429fm	12	24	allergy	allergy	NN
cord-328210-qhl429fm	12	25	.	.	.
cord-328210-qhl429fm	13	1	3	3	LS
cord-328210-qhl429fm	13	2	Type	type	NN
cord-328210-qhl429fm	13	3	2	2	CD
cord-328210-qhl429fm	13	4	inflammation	inflammation	NN
cord-328210-qhl429fm	13	5	leads	lead	VBZ
cord-328210-qhl429fm	13	6	to	to	IN
cord-328210-qhl429fm	13	7	eosinophils	eosinophils	NN
cord-328210-qhl429fm	13	8	and	and	CC
cord-328210-qhl429fm	13	9	mast	mast	NN
cord-328210-qhl429fm	13	10	cells	cell	NNS
cord-328210-qhl429fm	13	11	recruitment	recruitment	NN
cord-328210-qhl429fm	13	12	and	and	CC
cord-328210-qhl429fm	13	13	activation	activation	NN
cord-328210-qhl429fm	13	14	in	in	IN
cord-328210-qhl429fm	13	15	upper	upper	JJ
cord-328210-qhl429fm	13	16	airways	airway	NNS
cord-328210-qhl429fm	13	17	.	.	.
cord-328210-qhl429fm	14	1	Therefore	therefore	RB
cord-328210-qhl429fm	14	2	,	,	,
cord-328210-qhl429fm	14	3	to	to	TO
cord-328210-qhl429fm	14	4	document	document	VB
cord-328210-qhl429fm	14	5	the	the	DT
cord-328210-qhl429fm	14	6	presence	presence	NN
cord-328210-qhl429fm	14	7	of	of	IN
cord-328210-qhl429fm	14	8	inflammatory	inflammatory	JJ
cord-328210-qhl429fm	14	9	cells	cell	NNS
cord-328210-qhl429fm	14	10	in	in	IN
cord-328210-qhl429fm	14	11	the	the	DT
cord-328210-qhl429fm	14	12	nose	nose	NN
cord-328210-qhl429fm	14	13	by	by	IN
cord-328210-qhl429fm	14	14	nasal	nasal	NN
cord-328210-qhl429fm	14	15	cytology	cytology	NN
cord-328210-qhl429fm	14	16	is	be	VBZ
cord-328210-qhl429fm	14	17	a	a	DT
cord-328210-qhl429fm	14	18	simple	simple	JJ
cord-328210-qhl429fm	14	19	and	and	CC
cord-328210-qhl429fm	14	20	fruitful	fruitful	JJ
cord-328210-qhl429fm	14	21	way	way	NN
cord-328210-qhl429fm	14	22	to	to	TO
cord-328210-qhl429fm	14	23	assess	assess	VB
cord-328210-qhl429fm	14	24	the	the	DT
cord-328210-qhl429fm	14	25	severity	severity	NN
cord-328210-qhl429fm	14	26	of	of	IN
cord-328210-qhl429fm	14	27	disease	disease	NN
cord-328210-qhl429fm	14	28	and	and	CC
cord-328210-qhl429fm	14	29	evaluate	evaluate	VB
cord-328210-qhl429fm	14	30	the	the	DT
cord-328210-qhl429fm	14	31	response	response	NN
cord-328210-qhl429fm	14	32	to	to	IN
cord-328210-qhl429fm	14	33	treatments	treatment	NNS
cord-328210-qhl429fm	14	34	.	.	.
cord-328210-qhl429fm	15	1	4	4	LS
cord-328210-qhl429fm	16	1	Nasal	nasal	NN
cord-328210-qhl429fm	16	2	cytology	cytology	NN
cord-328210-qhl429fm	16	3	is	be	VBZ
cord-328210-qhl429fm	16	4	a	a	DT
cord-328210-qhl429fm	16	5	wellstandardized	wellstandardized	JJ
cord-328210-qhl429fm	16	6	method	method	NN
cord-328210-qhl429fm	16	7	that	that	WDT
cord-328210-qhl429fm	16	8	may	may	MD
cord-328210-qhl429fm	16	9	be	be	VB
cord-328210-qhl429fm	16	10	applied	apply	VBN
cord-328210-qhl429fm	16	11	to	to	IN
cord-328210-qhl429fm	16	12	all	all	DT
cord-328210-qhl429fm	16	13	nasal	nasal	JJ
cord-328210-qhl429fm	16	14	inflammatory	inflammatory	JJ
cord-328210-qhl429fm	16	15	disorders	disorder	NNS
cord-328210-qhl429fm	16	16	.	.	.
cord-328210-qhl429fm	17	1	5	5	LS
cord-328210-qhl429fm	18	1	Therefore	therefore	RB
cord-328210-qhl429fm	18	2	,	,	,
cord-328210-qhl429fm	18	3	nasal	nasal	NN
cord-328210-qhl429fm	18	4	cytology	cytology	NN
cord-328210-qhl429fm	18	5	may	may	MD
cord-328210-qhl429fm	18	6	be	be	VB
cord-328210-qhl429fm	18	7	performed	perform	VBN
cord-328210-qhl429fm	18	8	as	as	IN
cord-328210-qhl429fm	18	9	a	a	DT
cord-328210-qhl429fm	18	10	useful	useful	JJ
cord-328210-qhl429fm	18	11	step	step	NN
cord-328210-qhl429fm	18	12	in	in	IN
cord-328210-qhl429fm	18	13	the	the	DT
cord-328210-qhl429fm	18	14	workup	workup	NN
cord-328210-qhl429fm	18	15	of	of	IN
cord-328210-qhl429fm	18	16	patients	patient	NNS
cord-328210-qhl429fm	18	17	with	with	IN
cord-328210-qhl429fm	18	18	CRSwNP	crswnp	NN
cord-328210-qhl429fm	18	19	.	.	.
cord-328210-qhl429fm	19	1	As	as	IN
cord-328210-qhl429fm	19	2	a	a	DT
cord-328210-qhl429fm	19	3	consequence	consequence	NN
cord-328210-qhl429fm	19	4	,	,	,
cord-328210-qhl429fm	19	5	a	a	DT
cord-328210-qhl429fm	19	6	clinical	clinical	JJ
cord-328210-qhl429fm	19	7	cytological	cytological	JJ
cord-328210-qhl429fm	19	8	grading	grading	NN
cord-328210-qhl429fm	19	9	(	(	-LRB-
cord-328210-qhl429fm	19	10	CCG	CCG	NNP
cord-328210-qhl429fm	19	11	)	)	-RRB-
cord-328210-qhl429fm	19	12	,	,	,
cord-328210-qhl429fm	19	13	including	include	VBG
cord-328210-qhl429fm	19	14	the	the	DT
cord-328210-qhl429fm	19	15	documentation	documentation	NN
cord-328210-qhl429fm	19	16	of	of	IN
cord-328210-qhl429fm	19	17	possible	possible	JJ
cord-328210-qhl429fm	19	18	asthma	asthma	NN
cord-328210-qhl429fm	19	19	,	,	,
cord-328210-qhl429fm	19	20	allergy	allergy	NN
cord-328210-qhl429fm	19	21	,	,	,
cord-328210-qhl429fm	19	22	or	or	CC
cord-328210-qhl429fm	19	23	aspirin	aspirin	NN
cord-328210-qhl429fm	19	24	sensitivity	sensitivity	NN
cord-328210-qhl429fm	19	25	comorbidity	comorbidity	NN
cord-328210-qhl429fm	19	26	,	,	,
cord-328210-qhl429fm	19	27	and	and	CC
cord-328210-qhl429fm	19	28	the	the	DT
cord-328210-qhl429fm	19	29	presence	presence	NN
cord-328210-qhl429fm	19	30	of	of	IN
cord-328210-qhl429fm	19	31	eosinophils	eosinophil	NNS
cord-328210-qhl429fm	19	32	and/or	and/or	CC
cord-328210-qhl429fm	19	33	mast	mast	NN
cord-328210-qhl429fm	19	34	cells	cell	NNS
cord-328210-qhl429fm	19	35	in	in	IN
cord-328210-qhl429fm	19	36	the	the	DT
cord-328210-qhl429fm	19	37	nose	nose	NN
cord-328210-qhl429fm	19	38	,	,	,
cord-328210-qhl429fm	19	39	has	have	VBZ
cord-328210-qhl429fm	19	40	been	be	VBN
cord-328210-qhl429fm	19	41	proposed	propose	VBN
cord-328210-qhl429fm	19	42	as	as	IN
cord-328210-qhl429fm	19	43	a	a	DT
cord-328210-qhl429fm	19	44	precision	precision	NN
cord-328210-qhl429fm	19	45	medicine	medicine	NN
cord-328210-qhl429fm	19	46	-	-	HYPH
cord-328210-qhl429fm	19	47	based	base	VBN
cord-328210-qhl429fm	19	48	approach	approach	NN
cord-328210-qhl429fm	19	49	in	in	IN
cord-328210-qhl429fm	19	50	the	the	DT
cord-328210-qhl429fm	19	51	management	management	NN
cord-328210-qhl429fm	19	52	of	of	IN
cord-328210-qhl429fm	19	53	patients	patient	NNS
cord-328210-qhl429fm	19	54	with	with	IN
cord-328210-qhl429fm	19	55	CRSwNP	crswnp	NN
cord-328210-qhl429fm	19	56	.	.	.
cord-328210-qhl429fm	19	57	6	6	CD
cord-328210-qhl429fm	20	1	In	in	IN
cord-328210-qhl429fm	20	2	particular	particular	JJ
cord-328210-qhl429fm	20	3	,	,	,
cord-328210-qhl429fm	20	4	3	3	CD
cord-328210-qhl429fm	20	5	CCG	CCG	NNP
cord-328210-qhl429fm	20	6	grades	grade	NNS
cord-328210-qhl429fm	20	7	were	be	VBD
cord-328210-qhl429fm	20	8	defined	define	VBN
cord-328210-qhl429fm	20	9	on	on	IN
cord-328210-qhl429fm	20	10	the	the	DT
cord-328210-qhl429fm	20	11	basis	basis	NN
cord-328210-qhl429fm	20	12	of	of	IN
cord-328210-qhl429fm	20	13	the	the	DT
cord-328210-qhl429fm	20	14	score	score	NN
cord-328210-qhl429fm	20	15	:	:	:
cord-328210-qhl429fm	20	16	low	low	JJ
cord-328210-qhl429fm	20	17	(	(	-LRB-
cord-328210-qhl429fm	20	18	1	1	CD
cord-328210-qhl429fm	20	19	-	-	SYM
cord-328210-qhl429fm	20	20	3	3	CD
cord-328210-qhl429fm	20	21	)	)	-RRB-
cord-328210-qhl429fm	20	22	,	,	,
cord-328210-qhl429fm	20	23	medium	medium	NN
cord-328210-qhl429fm	20	24	(	(	-LRB-
cord-328210-qhl429fm	20	25	4	4	CD
cord-328210-qhl429fm	20	26	-	-	SYM
cord-328210-qhl429fm	20	27	6	6	CD
cord-328210-qhl429fm	20	28	)	)	-RRB-
cord-328210-qhl429fm	20	29	,	,	,
cord-328210-qhl429fm	20	30	and	and	CC
cord-328210-qhl429fm	20	31	high	high	JJ
cord-328210-qhl429fm	20	32	(	(	-LRB-
cord-328210-qhl429fm	20	33	>	>	XX
cord-328210-qhl429fm	20	34	_	_	NN
cord-328210-qhl429fm	20	35	7	7	CD
cord-328210-qhl429fm	20	36	)	)	-RRB-
cord-328210-qhl429fm	20	37	.	.	.
cord-328210-qhl429fm	21	1	A	a	DT
cord-328210-qhl429fm	21	2	recent	recent	JJ
cord-328210-qhl429fm	21	3	study	study	NN
cord-328210-qhl429fm	21	4	provided	provide	VBD
cord-328210-qhl429fm	21	5	evidence	evidence	NN
cord-328210-qhl429fm	21	6	that	that	IN
cord-328210-qhl429fm	21	7	a	a	DT
cord-328210-qhl429fm	21	8	CCG	CCG	NNP
cord-328210-qhl429fm	21	9	value	value	NN
cord-328210-qhl429fm	21	10	of	of	IN
cord-328210-qhl429fm	21	11	more	more	JJR
cord-328210-qhl429fm	21	12	than	than	IN
cord-328210-qhl429fm	21	13	4	4	CD
cord-328210-qhl429fm	21	14	was	be	VBD
cord-328210-qhl429fm	21	15	a	a	DT
cord-328210-qhl429fm	21	16	reliable	reliable	JJ
cord-328210-qhl429fm	21	17	(	(	-LRB-
cord-328210-qhl429fm	21	18	area	area	NN
cord-328210-qhl429fm	21	19	under	under	IN
cord-328210-qhl429fm	21	20	the	the	DT
cord-328210-qhl429fm	21	21	curve	curve	NN
cord-328210-qhl429fm	21	22	,	,	,
cord-328210-qhl429fm	21	23	0.83	0.83	CD
cord-328210-qhl429fm	21	24	,	,	,
cord-328210-qhl429fm	21	25	and	and	CC
cord-328210-qhl429fm	21	26	adjusted	adjust	VBN
cord-328210-qhl429fm	21	27	odds	odd	NNS
cord-328210-qhl429fm	21	28	ratio	ratio	NN
cord-328210-qhl429fm	21	29	,	,	,
cord-328210-qhl429fm	21	30	7.46	7.46	CD
cord-328210-qhl429fm	21	31	)	)	-RRB-
cord-328210-qhl429fm	21	32	cutoff	cutoff	NN
cord-328210-qhl429fm	21	33	to	to	TO
cord-328210-qhl429fm	21	34	identify	identify	VB
cord-328210-qhl429fm	21	35	patients	patient	NNS
cord-328210-qhl429fm	21	36	with	with	IN
cord-328210-qhl429fm	21	37	CRSwNP	CRSwNP	VBN
cord-328210-qhl429fm	21	38	with	with	IN
cord-328210-qhl429fm	21	39	olfactory	olfactory	JJ
cord-328210-qhl429fm	21	40	dysfunction	dysfunction	NN
cord-328210-qhl429fm	21	41	.	.	.
cord-328210-qhl429fm	22	1	7	7	CD
cord-328210-qhl429fm	23	1	Smell	smell	JJ
cord-328210-qhl429fm	23	2	loss	loss	NN
cord-328210-qhl429fm	23	3	is	be	VBZ
cord-328210-qhl429fm	23	4	a	a	DT
cord-328210-qhl429fm	23	5	clinical	clinical	JJ
cord-328210-qhl429fm	23	6	marker	marker	NN
cord-328210-qhl429fm	23	7	of	of	IN
cord-328210-qhl429fm	23	8	CRSwNP	crswnp	JJ
cord-328210-qhl429fm	23	9	severity	severity	NN
cord-328210-qhl429fm	23	10	and	and	CC
cord-328210-qhl429fm	23	11	is	be	VBZ
cord-328210-qhl429fm	23	12	associated	associate	VBN
cord-328210-qhl429fm	23	13	with	with	IN
cord-328210-qhl429fm	23	14	type	type	NN
cord-328210-qhl429fm	23	15	2	2	CD
cord-328210-qhl429fm	23	16	inflammation	inflammation	NN
cord-328210-qhl429fm	23	17	:	:	:
cord-328210-qhl429fm	23	18	both	both	DT
cord-328210-qhl429fm	23	19	conditions	condition	NNS
cord-328210-qhl429fm	23	20	indicate	indicate	VBP
cord-328210-qhl429fm	23	21	a	a	DT
cord-328210-qhl429fm	23	22	biological	biological	JJ
cord-328210-qhl429fm	23	23	approach	approach	NN
cord-328210-qhl429fm	23	24	.	.	.
cord-328210-qhl429fm	24	1	1	1	LS
cord-328210-qhl429fm	25	1	The	the	DT
cord-328210-qhl429fm	25	2	CRSwNP	crswnp	JJ
cord-328210-qhl429fm	25	3	overall	overall	JJ
cord-328210-qhl429fm	25	4	prevalence	prevalence	NN
cord-328210-qhl429fm	25	5	has	have	VBZ
cord-328210-qhl429fm	25	6	been	be	VBN
cord-328210-qhl429fm	25	7	approximately	approximately	RB
cord-328210-qhl429fm	25	8	estimated	estimate	VBN
cord-328210-qhl429fm	25	9	to	to	TO
cord-328210-qhl429fm	25	10	be	be	VB
cord-328210-qhl429fm	25	11	2	2	CD
cord-328210-qhl429fm	25	12	%	%	NN
cord-328210-qhl429fm	25	13	to	to	TO
cord-328210-qhl429fm	25	14	4	4	CD
cord-328210-qhl429fm	25	15	%	%	NN
cord-328210-qhl429fm	25	16	of	of	IN
cord-328210-qhl429fm	25	17	the	the	DT
cord-328210-qhl429fm	25	18	general	general	JJ
cord-328210-qhl429fm	25	19	population	population	NN
cord-328210-qhl429fm	25	20	and	and	CC
cord-328210-qhl429fm	25	21	approximately	approximately	RB
cord-328210-qhl429fm	25	22	30	30	CD
cord-328210-qhl429fm	25	23	%	%	NN
cord-328210-qhl429fm	25	24	of	of	IN
cord-328210-qhl429fm	25	25	these	these	DT
cord-328210-qhl429fm	25	26	patients	patient	NNS
cord-328210-qhl429fm	25	27	also	also	RB
cord-328210-qhl429fm	25	28	have	have	VBP
cord-328210-qhl429fm	25	29	asthma	asthma	NN
cord-328210-qhl429fm	25	30	.	.	.
cord-328210-qhl429fm	26	1	2	2	LS
cord-328210-qhl429fm	27	1	On	on	IN
cord-328210-qhl429fm	27	2	the	the	DT
cord-328210-qhl429fm	27	3	basis	basis	NN
cord-328210-qhl429fm	27	4	of	of	IN
cord-328210-qhl429fm	27	5	these	these	DT
cord-328210-qhl429fm	27	6	epidemiological	epidemiological	JJ
cord-328210-qhl429fm	27	7	considerations	consideration	NNS
cord-328210-qhl429fm	27	8	,	,	,
cord-328210-qhl429fm	27	9	a	a	DT
cord-328210-qhl429fm	27	10	large	large	JJ
cord-328210-qhl429fm	27	11	group	group	NN
cord-328210-qhl429fm	27	12	of	of	IN
cord-328210-qhl429fm	27	13	Italian	italian	JJ
cord-328210-qhl429fm	27	14	outpatients	outpatient	NNS
cord-328210-qhl429fm	27	15	with	with	IN
cord-328210-qhl429fm	27	16	CRSwNP	crswnp	NN
cord-328210-qhl429fm	27	17	(	(	-LRB-
cord-328210-qhl429fm	27	18	791	791	CD
cord-328210-qhl429fm	27	19	;	;	:
cord-328210-qhl429fm	27	20	424	424	CD
cord-328210-qhl429fm	27	21	males	male	NNS
cord-328210-qhl429fm	27	22	,	,	,
cord-328210-qhl429fm	27	23	mean	mean	VB
cord-328210-qhl429fm	27	24	age	age	NN
cord-328210-qhl429fm	27	25	,	,	,
cord-328210-qhl429fm	27	26	48.8	48.8	CD
cord-328210-qhl429fm	27	27	years	year	NNS
cord-328210-qhl429fm	27	28	)	)	-RRB-
cord-328210-qhl429fm	27	29	was	be	VBD
cord-328210-qhl429fm	27	30	recruited	recruit	VBN
cord-328210-qhl429fm	27	31	in	in	IN
cord-328210-qhl429fm	27	32	a	a	DT
cord-328210-qhl429fm	27	33	real	real	JJ
cord-328210-qhl429fm	27	34	-	-	HYPH
cord-328210-qhl429fm	27	35	world	world	NN
cord-328210-qhl429fm	27	36	study	study	NN
cord-328210-qhl429fm	27	37	to	to	TO
cord-328210-qhl429fm	27	38	define	define	VB
cord-328210-qhl429fm	27	39	the	the	DT
cord-328210-qhl429fm	27	40	distribution	distribution	NN
cord-328210-qhl429fm	27	41	of	of	IN
cord-328210-qhl429fm	27	42	the	the	DT
cord-328210-qhl429fm	27	43	CCG	CCG	NNP
cord-328210-qhl429fm	27	44	grades	grade	NNS
cord-328210-qhl429fm	27	45	.	.	.
cord-328210-qhl429fm	28	1	The	the	DT
cord-328210-qhl429fm	28	2	preliminary	preliminary	JJ
cord-328210-qhl429fm	28	3	results	result	NNS
cord-328210-qhl429fm	28	4	showed	show	VBD
cord-328210-qhl429fm	28	5	that	that	IN
cord-328210-qhl429fm	28	6	210	210	CD
cord-328210-qhl429fm	28	7	(	(	-LRB-
cord-328210-qhl429fm	28	8	26.5	26.5	CD
cord-328210-qhl429fm	28	9	%	%	NN
cord-328210-qhl429fm	28	10	)	)	-RRB-
cord-328210-qhl429fm	28	11	outpatients	outpatient	NNS
cord-328210-qhl429fm	28	12	had	have	VBD
cord-328210-qhl429fm	28	13	low	low	JJ
cord-328210-qhl429fm	28	14	-	-	HYPH
cord-328210-qhl429fm	28	15	grade	grade	NN
cord-328210-qhl429fm	28	16	CCG	CCG	NNP
cord-328210-qhl429fm	28	17	,	,	,
cord-328210-qhl429fm	28	18	366	366	CD
cord-328210-qhl429fm	28	19	(	(	-LRB-
cord-328210-qhl429fm	28	20	46.3	46.3	CD
cord-328210-qhl429fm	28	21	%	%	NN
cord-328210-qhl429fm	28	22	)	)	-RRB-
cord-328210-qhl429fm	28	23	medium	medium	NN
cord-328210-qhl429fm	28	24	,	,	,
cord-328210-qhl429fm	28	25	and	and	CC
cord-328210-qhl429fm	28	26	215	215	CD
cord-328210-qhl429fm	28	27	(	(	-LRB-
cord-328210-qhl429fm	28	28	27.2	27.2	CD
cord-328210-qhl429fm	28	29	%	%	NN
cord-328210-qhl429fm	28	30	)	)	-RRB-
cord-328210-qhl429fm	28	31	high	high	JJ
cord-328210-qhl429fm	29	1	(	(	-LRB-
cord-328210-qhl429fm	29	2	Fig	Fig	NNP
cord-328210-qhl429fm	29	3	1	1	CD
cord-328210-qhl429fm	29	4	)	)	-RRB-
cord-328210-qhl429fm	29	5	.	.	.
cord-328210-qhl429fm	30	1	High	high	JJ
cord-328210-qhl429fm	30	2	-	-	HYPH
cord-328210-qhl429fm	30	3	grade	grade	NN
cord-328210-qhl429fm	30	4	CCG	CCG	NNP
cord-328210-qhl429fm	30	5	was	be	VBD
cord-328210-qhl429fm	30	6	frequently	frequently	RB
cord-328210-qhl429fm	30	7	characterized	characterize	VBN
cord-328210-qhl429fm	30	8	by	by	IN
cord-328210-qhl429fm	30	9	mixed	mixed	JJ
cord-328210-qhl429fm	30	10	cytological	cytological	JJ
cord-328210-qhl429fm	30	11	phenotype	phenotype	NN
cord-328210-qhl429fm	30	12	and	and	CC
cord-328210-qhl429fm	30	13	severe	severe	JJ
cord-328210-qhl429fm	30	14	progress	progress	NN
cord-328210-qhl429fm	30	15	.	.	.
cord-328210-qhl429fm	31	1	Patients	patient	NNS
cord-328210-qhl429fm	31	2	with	with	IN
cord-328210-qhl429fm	31	3	CRSwNP	CRSwNP	NNP
cord-328210-qhl429fm	31	4	deserve	deserve	VB
cord-328210-qhl429fm	31	5	adequate	adequate	JJ
cord-328210-qhl429fm	31	6	management	management	NN
cord-328210-qhl429fm	31	7	and	and	CC
cord-328210-qhl429fm	31	8	optimal	optimal	JJ
cord-328210-qhl429fm	31	9	identification	identification	NN
cord-328210-qhl429fm	31	10	of	of	IN
cord-328210-qhl429fm	31	11	the	the	DT
cord-328210-qhl429fm	31	12	besttailored	besttailored	JJ
cord-328210-qhl429fm	31	13	therapy	therapy	NN
cord-328210-qhl429fm	31	14	;	;	:
cord-328210-qhl429fm	31	15	in	in	IN
cord-328210-qhl429fm	31	16	this	this	DT
cord-328210-qhl429fm	31	17	regard	regard	NN
cord-328210-qhl429fm	31	18	,	,	,
cord-328210-qhl429fm	31	19	CCG	CCG	NNP
cord-328210-qhl429fm	31	20	could	could	MD
cord-328210-qhl429fm	31	21	be	be	VB
cord-328210-qhl429fm	31	22	a	a	DT
cord-328210-qhl429fm	31	23	fruitful	fruitful	JJ
cord-328210-qhl429fm	31	24	tool	tool	NN
cord-328210-qhl429fm	31	25	.	.	.
cord-328210-qhl429fm	32	1	In	in	IN
cord-328210-qhl429fm	32	2	particular	particular	JJ
cord-328210-qhl429fm	32	3	,	,	,
cord-328210-qhl429fm	32	4	considering	consider	VBG
cord-328210-qhl429fm	32	5	the	the	DT
cord-328210-qhl429fm	32	6	estimated	estimate	VBN
cord-328210-qhl429fm	32	7	prevalence	prevalence	NN
cord-328210-qhl429fm	32	8	of	of	IN
cord-328210-qhl429fm	32	9	CRSwNP	crswnp	NN
cord-328210-qhl429fm	32	10	and	and	CC
cord-328210-qhl429fm	32	11	the	the	DT
cord-328210-qhl429fm	32	12	current	current	JJ
cord-328210-qhl429fm	32	13	findings	finding	NNS
cord-328210-qhl429fm	32	14	,	,	,
cord-328210-qhl429fm	32	15	it	-PRON-	PRP
cord-328210-qhl429fm	32	16	could	could	MD
cord-328210-qhl429fm	32	17	be	be	VB
cord-328210-qhl429fm	32	18	reasonably	reasonably	RB
cord-328210-qhl429fm	32	19	expected	expect	VBN
cord-328210-qhl429fm	32	20	that	that	IN
cord-328210-qhl429fm	32	21	at	at	RB
cord-328210-qhl429fm	32	22	least	least	JJS
cord-328210-qhl429fm	32	23	5	5	CD
cord-328210-qhl429fm	32	24	million	million	CD
cord-328210-qhl429fm	32	25	Europeans	Europeans	NNPS
cord-328210-qhl429fm	32	26	have	have	VBP
cord-328210-qhl429fm	32	27	CRSwNP	CRSwNP	VBN
cord-328210-qhl429fm	32	28	with	with	IN
cord-328210-qhl429fm	32	29	high	high	JJ
cord-328210-qhl429fm	32	30	-	-	HYPH
cord-328210-qhl429fm	32	31	grade	grade	NN
cord-328210-qhl429fm	32	32	CCG	ccg	NN
cord-328210-qhl429fm	32	33	.	.	.
cord-328210-qhl429fm	33	1	Therefore	therefore	RB
cord-328210-qhl429fm	33	2	,	,	,
cord-328210-qhl429fm	33	3	intercepting	intercept	VBG
cord-328210-qhl429fm	33	4	the	the	DT
cord-328210-qhl429fm	33	5	most	most	RBS
cord-328210-qhl429fm	33	6	severe	severe	JJ
cord-328210-qhl429fm	33	7	patients	patient	NNS
cord-328210-qhl429fm	33	8	and	and	CC
cord-328210-qhl429fm	33	9	launching	launch	VBG
cord-328210-qhl429fm	33	10	an	an	DT
cord-328210-qhl429fm	33	11	early	early	JJ
cord-328210-qhl429fm	33	12	and	and	CC
cord-328210-qhl429fm	33	13	tailored	tailor	VBN
cord-328210-qhl429fm	33	14	treatment	treatment	NN
cord-328210-qhl429fm	33	15	,	,	,
cord-328210-qhl429fm	33	16	including	include	VBG
cord-328210-qhl429fm	33	17	the	the	DT
cord-328210-qhl429fm	33	18	new	new	JJ
cord-328210-qhl429fm	33	19	biologics	biologic	NNS
cord-328210-qhl429fm	33	20	,	,	,
cord-328210-qhl429fm	33	21	could	could	MD
cord-328210-qhl429fm	33	22	positively	positively	RB
cord-328210-qhl429fm	33	23	modify	modify	VB
cord-328210-qhl429fm	33	24	the	the	DT
cord-328210-qhl429fm	33	25	natural	natural	JJ
cord-328210-qhl429fm	33	26	history	history	NN
cord-328210-qhl429fm	33	27	and	and	CC
cord-328210-qhl429fm	33	28	improve	improve	VB
cord-328210-qhl429fm	33	29	the	the	DT
cord-328210-qhl429fm	33	30	quality	quality	NN
cord-328210-qhl429fm	33	31	of	of	IN
cord-328210-qhl429fm	33	32	life	life	NN
cord-328210-qhl429fm	33	33	.	.	.
cord-328210-qhl429fm	34	1	The	the	DT
cord-328210-qhl429fm	34	2	sense	sense	NN
cord-328210-qhl429fm	34	3	of	of	IN
cord-328210-qhl429fm	34	4	smell	smell	NN
cord-328210-qhl429fm	34	5	in	in	IN
cord-328210-qhl429fm	34	6	chronic	chronic	JJ
cord-328210-qhl429fm	34	7	rhinosinusitis	rhinosinusitis	NN
cord-328210-qhl429fm	34	8	EPOS2020	EPOS2020	NNP
cord-328210-qhl429fm	34	9	:	:	:
cord-328210-qhl429fm	35	1	European	European	NNP
cord-328210-qhl429fm	35	2	Position	Position	NNP
cord-328210-qhl429fm	35	3	Paper	Paper	NNP
cord-328210-qhl429fm	35	4	on	on	IN
cord-328210-qhl429fm	35	5	Rhinosinusitis	Rhinosinusitis	NNP
cord-328210-qhl429fm	35	6	and	and	CC
cord-328210-qhl429fm	35	7	Nasal	Nasal	NNP
cord-328210-qhl429fm	35	8	Polyps	Polyps	NNPS
cord-328210-qhl429fm	35	9	2020	2020	CD
cord-328210-qhl429fm	35	10	EUFOREA	EUFOREA	NNP
cord-328210-qhl429fm	35	11	consensus	consensus	NN
cord-328210-qhl429fm	35	12	on	on	IN
cord-328210-qhl429fm	35	13	biologics	biologic	NNS
cord-328210-qhl429fm	35	14	for	for	IN
cord-328210-qhl429fm	35	15	CRSwNP	CRSwNP	VBN
cord-328210-qhl429fm	35	16	with	with	IN
cord-328210-qhl429fm	35	17	or	or	CC
cord-328210-qhl429fm	35	18	without	without	IN
cord-328210-qhl429fm	35	19	asthma	asthma	NN
cord-328210-qhl429fm	35	20	Role	role	NN
cord-328210-qhl429fm	35	21	of	of	IN
cord-328210-qhl429fm	35	22	nasal	nasal	NN
cord-328210-qhl429fm	35	23	cytology	cytology	NN
cord-328210-qhl429fm	35	24	Standardization	Standardization	NNP
cord-328210-qhl429fm	35	25	of	of	IN
cord-328210-qhl429fm	35	26	the	the	DT
cord-328210-qhl429fm	35	27	nasal	nasal	NN
cord-328210-qhl429fm	35	28	cytology	cytology	NN
cord-328210-qhl429fm	35	29	in	in	IN
cord-328210-qhl429fm	35	30	the	the	DT
cord-328210-qhl429fm	35	31	work	work	NN
cord-328210-qhl429fm	35	32	-	-	HYPH
cord-328210-qhl429fm	35	33	up	up	NN
cord-328210-qhl429fm	35	34	of	of	IN
cord-328210-qhl429fm	35	35	allergic	allergic	JJ
cord-328210-qhl429fm	35	36	rhinitis	rhinitis	NN
cord-328210-qhl429fm	35	37	Non	non	JJ
cord-328210-qhl429fm	35	38	-	-	JJ
cord-328210-qhl429fm	35	39	surgical	surgical	JJ
cord-328210-qhl429fm	35	40	management	management	NN
cord-328210-qhl429fm	35	41	of	of	IN
cord-328210-qhl429fm	35	42	chronic	chronic	JJ
cord-328210-qhl429fm	35	43	rhinosinusitis	rhinosinusitis	NN
cord-328210-qhl429fm	35	44	with	with	IN
cord-328210-qhl429fm	35	45	nasal	nasal	NN
cord-328210-qhl429fm	35	46	polyps	polyp	NNS
cord-328210-qhl429fm	35	47	based	base	VBN
cord-328210-qhl429fm	35	48	on	on	IN
cord-328210-qhl429fm	35	49	clinical	clinical	JJ
cord-328210-qhl429fm	35	50	cytological	cytological	JJ
cord-328210-qhl429fm	35	51	grading	grading	NN
cord-328210-qhl429fm	35	52	:	:	:
cord-328210-qhl429fm	35	53	a	a	DT
cord-328210-qhl429fm	35	54	precision	precision	NN
cord-328210-qhl429fm	35	55	medicine	medicine	NN
cord-328210-qhl429fm	35	56	-	-	HYPH
cord-328210-qhl429fm	35	57	based	base	VBN
cord-328210-qhl429fm	35	58	approach	approach	NN
cord-328210-qhl429fm	35	59	Olfactory	olfactory	JJ
cord-328210-qhl429fm	35	60	dysfunction	dysfunction	NN
cord-328210-qhl429fm	35	61	in	in	IN
cord-328210-qhl429fm	35	62	patients	patient	NNS
cord-328210-qhl429fm	35	63	with	with	IN
cord-328210-qhl429fm	35	64	chronic	chronic	JJ
cord-328210-qhl429fm	35	65	rhinosinusitis	rhinosinusitis	NN
cord-328210-qhl429fm	35	66	with	with	IN
cord-328210-qhl429fm	35	67	nasal	nasal	NN
cord-328210-qhl429fm	35	68	polyps	polyp	NNS
cord-328210-qhl429fm	35	69	is	be	VBZ
cord-328210-qhl429fm	35	70	associated	associate	VBN
cord-328210-qhl429fm	35	71	with	with	IN
cord-328210-qhl429fm	35	72	clinical	clinical	JJ
cord-328210-qhl429fm	35	73	-	-	HYPH
cord-328210-qhl429fm	35	74	cytological	cytological	JJ
cord-328210-qhl429fm	35	75	grading	grading	NN
cord-328210-qhl429fm	35	76	severity	severity	NN